EUDA Health Holdings Limited Form 6-K Summary
Business context and reporting period
EUDA Health Holdings Limited, a foreign private issuer filing Form 20-F, furnished this Form 6-K for September 2023. The report was dated September 22, 2023 and disclosed updates regarding compliance with Nasdaq continued-listing requirements.
Key financial metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial performance measures.
Material changes versus the prior comparable period
- On September 14, 2023, Nasdaq notified EUDA that it had regained compliance with the $1.00 minimum bid price requirement after its closing bid price remained at or above $1.00 for 10 consecutive business days from August 30 through September 13, 2023.
- On September 20, 2023, Nasdaq notified EUDA that it had regained compliance with the $35 million minimum market value of listed securities requirement after meeting the threshold for 10 consecutive business days from September 6 through September 19, 2023.
- The company stated that all matters relating to its previous Nasdaq Capital Market non-compliance were closed.
Guidance, outlook, risks, contingencies, and unusual items
The filing provides no financial guidance or operating outlook. The principal disclosed risk concerned potential Nasdaq continued-listing compliance; based on the notices described, that issue was resolved as of September 20, 2023.
Important facts for investors to verify
- Confirm the Nasdaq notices and the dates of the bid-price and market-value compliance periods.
- Verify that no additional Nasdaq listing deficiencies or subsequent compliance notices arose after September 20, 2023.
- Review the company’s periodic reports for financial condition, liquidity, operating performance, and any risks not addressed in this Form 6-K.